GGrantIndex
← Leaderboards

David Charles Lyden

Weill Medical College Of Cornell Univ

$14,066,044
Attributed
$22,212,498
Total exposure
10
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.6M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$22,212,498 · 10

By mechanism

R01$8,897,748 · 4
R35$6,967,594 · 1
U01$2,866,833 · 1
R61$1,675,237 · 1
R33$1,352,800 · 1
U19$452,286 · 2

Top collaborators

Most similar at Weill Medical College Of Cornell Univ

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsProteomicsExosomeTumorMediatingMalignant NeoplasmsProteinsPlasmaComplexCytokineNeoplasm MetastasisMolecularDiagnosisAffectChemokineHeterogeneityTumor-DerivedTargeted TreatmentGeneticParticleIn VitroBiological MarkersCancer PatientRegulation

Grant awards (41)

Abnormal Extracellular Vesicles and Particles from Human Islets Impact T1D progression$701,858
R01 · FY2025 · DK
Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection$474,405
R01 · FY2025 · CA · contact PI
In vitro modeling of blood brain barrier dysfunction on a chip to elucidate the pathogenesis of cerebral malaria$463,994
R33 · FY2025 · HL
Collaborative Project$253,828
U19 · FY2025 · AI · contact PI
Systemic regulation of metastasis$960,655
R35 · FY2024 · CA · contact PI
Abnormal Extracellular Vesicles and Particles from Human Islets Impact T1D progression$678,579
R01 · FY2024 · DK
Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection$453,986
R01 · FY2024 · CA · contact PI
In vitro modeling of blood brain barrier dysfunction on a chip to elucidate the pathogenesis of cerebral malaria$429,639
R33 · FY2024 · HL
Collaborative Project$113,708
U19 · FY2024 · AI · contact PI
Systemic regulation of metastasis$973,323
R35 · FY2023 · CA · contact PI
Abnormal Extracellular Vesicles and Particles from Human Islets Impact T1D progression$729,080
R01 · FY2023 · DK
Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection$488,306
R01 · FY2023 · CA · contact PI
In vitro modeling of blood brain barrier dysfunction on a chip to elucidate the pathogenesis of cerebral malaria$459,167
R33 · FY2023 · HL
Systemic regulation of metastasis$996,660
R35 · FY2022 · CA · contact PI
In vitro modeling of blood brain barrier dysfunction on a chip to elucidate the pathogenesis of cerebral malaria$827,608
R61 · FY2022 · HL
Systemic regulation of metastasis$1,017,000
R35 · FY2021 · CA · contact PI
In vitro modeling of blood brain barrier dysfunction on a chip to elucidate the pathogenesis of cerebral malaria$847,629
R61 · FY2021 · HL
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model$443,445
R01 · FY2021 · CA · contact PI
Systemic regulation of metastasis$1,016,466
R35 · FY2020 · CA · contact PI
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model$514,346
R01 · FY2020 · CA · contact PI
Systemic regulation of metastasis$986,490
R35 · FY2019 · CA · contact PI
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model$502,765
R01 · FY2019 · CA · contact PI
Functional role and biomarker potential of circulating exosomes in systemic autoimmune diseases$84,750
U19 · FY2019 · AI · contact PI
Systemic regulation of metastasis$1,017,000
R35 · FY2018 · CA · contact PI
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model$430,996
R01 · FY2018 · CA · contact PI
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model$70,783
R01 · FY2018 · CA · contact PI
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model$472,052
R01 · FY2017 · CA · contact PI
Exosome-mediated Transfer of c-MET to Bone Marrow Progenitors Promotes Metastasis$351,713
R01 · FY2017 · CA · contact PI
Characterization and Functional Analysis of Breast Cancer Secreted Exosomes in Ma$566,658
U01 · FY2016 · CA · contact PI
Exosome-mediated Transfer of c-MET to Bone Marrow Progenitors Promotes Metastasis$351,713
R01 · FY2016 · CA · contact PI
Characterization and Functional Analysis of Breast Cancer Secreted Exosomes in Ma$571,434
U01 · FY2015 · CA · contact PI
Exosome-mediated Transfer of c-MET to Bone Marrow Progenitors Promotes Metastasis$351,713
R01 · FY2015 · CA · contact PI
Characterization and Functional Analysis of Breast Cancer Secreted Exosomes in Ma$558,404
U01 · FY2014 · CA · contact PI
Exosome-mediated Transfer of c-MET to Bone Marrow Progenitors Promotes Metastasis$341,162
R01 · FY2014 · CA · contact PI
Characterization and Functional Analysis of Breast Cancer Secreted Exosomes in Ma$544,810
U01 · FY2013 · CA · contact PI
Exosome-mediated Transfer of c-MET to Bone Marrow Progenitors Promotes Metastasis$351,713
R01 · FY2013 · CA · contact PI
Characterization and Functional Analysis of Breast Cancer Secreted Exosomes in Ma$625,527
U01 · FY2012 · CA · contact PI
Regulation of tumor angiogenesis by Id+ marrow precursor$292,013
R01 · FY2006 · CA · contact PI
Regulation of tumor angiogenesis by Id+ marrow precursor$299,040
R01 · FY2005 · CA
Regulation of tumor angiogenesis by Id+ marrow precursor$299,040
R01 · FY2004 · CA
Regulation of tumor angiogenesis by Id+ marrow precursor$299,040
R01 · FY2003 · CA